BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24130964)

  • 1. Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.
    Jakopovic M; Thomas A; Balasubramaniam S; Schrump D; Giaccone G; Bates SE
    Front Oncol; 2013 Oct; 3():261. PubMed ID: 24130964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
    Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
    J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of epigenetic alterations in lung carcinogenesis.
    Brzeziańska E; Dutkowska A; Antczak A
    Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alteration and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Front Genet; 2013 Dec; 4():258. PubMed ID: 24348513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases.
    Vendetti FP; Rudin CM
    Expert Opin Biol Ther; 2013 Sep; 13(9):1273-85. PubMed ID: 23859704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of epigenetics and microRNA in hepatocellular carcinoma.
    Saito Y; Hibino S; Saito H
    Hepatol Res; 2014 Jan; 44(1):31-42. PubMed ID: 23617364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical and therapeutic profiles of DNA methylation alterations in cancer; an overview of changes in chromatin arrangement and alterations in histone surfaces.
    Norollahi SE; Vahidi S; Shams S; Keymoradzdeh A; Soleymanpour A; Solymanmanesh N; Mirzajani E; Jamkhaneh VB; Samadani AA
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):337-356. PubMed ID: 36799246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
    Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets.
    Bajbouj K; Al-Ali A; Ramakrishnan RK; Saber-Ayad M; Hamid Q
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
    Oh S; Ko JY; Oh C; Yoo KH
    Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer.
    Khin SS; Kitazawa R; Kondo T; Idei Y; Fujimoto M; Haraguchi R; Mori K; Kitazawa S
    Cancers (Basel); 2011 Mar; 3(1):982-93. PubMed ID: 24212650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.
    Digel W; Lübbert M
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):1-11. PubMed ID: 15886007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
    Juergens RA; Rudin CM
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in non-small cell lung cancer: from basics to therapeutics.
    Ansari J; Shackelford RE; El-Osta H
    Transl Lung Cancer Res; 2016 Apr; 5(2):155-71. PubMed ID: 27186511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic control of gene expression: Potential implications for cancer treatment.
    Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
    Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix.
    Saavedra KP; Brebi PM; Roa JC
    Clin Epigenetics; 2012 Aug; 4(1):13. PubMed ID: 22938091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.